Stockreport

Xeris Biopharma Subsidiaries File Recorlev® Patent Infringement Lawsuit

Xeris Biopharma Holdings, Inc.  (XERS) 
Last xeris biopharma holdings, inc. earnings: 3/11 06:00 am Check Earnings Report
PDF Four Orange Book Listed Patents through March 2040Orphan Drug Exclusivity through December 2028 CHICAGO--(BUSINESS WIRE)--Xeris Biopharma Holdings, Inc. (Nasdaq: XERS [Read more]